Continues to build Equity Platform with the addition of another senior analyst in the Healthcare vertical to cover Specialty Pharmaceutical and Biotechnology Companies.

New York – Tuesday, December 2, 2014 – Brean Capital, LLC today announces the addition of Dr. Difei Yang, as Managing Director and Senior Analyst covering Specialty Pharmaceutical and Biotechnology Companies. We are excited for Dr. Yang to join our team. She is a seasoned finance professional with 15+ years of experience in the Specialty Pharmaceutical and Biotechnology sectors and has evaluated and advised on hundreds of new business opportunities spanning the entire spectrum of pre-clinical through the phase III development stage, products in-license, out-license, life cycle management, co-development/co-marketing deals and out-right company acquisition.

Brean Capital is committed to continually refining our Research efforts to be more strategically aligned with the trends of the future and we see this hire as key to maintaining a fresh perspective in our Healthcare vertical. One of the sustainable competitive advantages of boutique investment banks is the ability to identify trends and quickly redeploy assets to better serve our clients’ needs. Our Research led strategy, strong capital position, momentum in all of our businesses and culture of collaboration allows us to continually upgrade our capabilities. We are excited about our continued evolution and look forward to expanding our Research platform.

Dr. Yang holds a Chemistry from University of California Los-Angeles and B.Sc. in Physics from Peking University , China as well as an MBA from Georgia State University. Prior to joining Brean, she was Managing Director covering Biotech/Specialty Pharmaceuticals at R.F. Lafferty, WallachBeth Capital, Auriga USA and Capstone Investments. Prior to her roles in equity research, Dr. Yang spent 14 years in the pharmaceutical/biotech industry in various functions, including R&D, marketing/sales, project management,  business development/M&A and business analytics. Dr. Yang’s industry experience spans companies such as Becton Dickinson, Solvay Pharmaceuticals, Kimberly Clark and SpectRx. Dr. Yang holds multiple US patents and has authored many scientific publications.